AVENUE THERAPEUTICS, INC. (ticker: ATXI) is an OTC-listed pharma company. DredgeCap's structured extraction of ATXI's SEC filings surfaces 2 active risk signals, including 1 auditor-change signal, and 1 delisting/deregistration signal. ATXI reported $1.40M in revenue and -$695K for the period ending 2025-12-31, with operating cash flow of -$438K. Cash and equivalents stood at $2.42M (down 31% year-over-year). Total assets of $2.47M exceed total liabilities of $1.27M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
ATXI Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for AVENUE THERAPEUTICS, INC. (ATXI) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.